Finding the right psychiatric medication can take time. Some people respond well to the first medication they try. Others have side effects, limited benefit, or a pattern of “nothing seems to work.”
One reason medication response varies is that people metabolize medications differently. Pharmacogenomic testing looks at certain genes involved in medication metabolism and response. The goal is not to predict the perfect medication. The goal is to give your clinician another piece of information when making medication decisions.
At Dignity Brain Health, pharmacogenomic testing may be considered as part of psychiatric medication management. It is not a standalone substitute for a clinical evaluation, and it does not replace the judgment of a licensed clinician.
Quick Answer: What Is Genetic Testing for Psychiatric Medications?
Genetic testing for psychiatric medications, also called pharmacogenomic testing, analyzes selected genes that may affect how your body processes certain medications.
The results may help your clinician understand whether some medications could require more caution, dose adjustment, closer monitoring, or a different prescribing approach. The test does not diagnose depression, anxiety, ADHD, PTSD, OCD, or any other psychiatric condition. It also does not guarantee that a specific medication will work.
Dignity Brain Health offers pharmacogenomic testing as part of psychiatric medication management. Sample collection is available in person at our Brookline, Massachusetts office near Boston.
What Is Pharmacogenomic Testing?
Pharmacogenomic testing looks at genetic variations that may affect how medications are metabolized or tolerated.
In psychiatry, some of the most relevant genes involve liver enzymes that help process medications. If a person metabolizes a medication more slowly than expected, the medication may stay in the body longer and increase the risk of side effects. If a person metabolizes a medication more quickly than expected, the medication may not remain at expected levels.
This information can be useful, but it is not the whole story. Medication response also depends on diagnosis, symptoms, dose, duration, other medications, medical conditions, side effects, adherence, sleep, substance use, and many other clinical factors.
What Genetic Testing Can Tell You
Pharmacogenomic testing may provide information about:
- How your body may metabolize certain medications
- Whether some medications may require extra caution
- Whether dose adjustment or closer monitoring may be relevant
- Whether prior side effects might have a metabolism-related explanation
- Whether certain medication options deserve further discussion with your clinician
The results are one data point. They should be interpreted in the context of your symptoms, diagnosis, prior medication trials, side effects, medical history, and treatment goals.
What Genetic Testing Cannot Tell You
Pharmacogenomic testing cannot tell you everything about psychiatric medication response.
It does not:
- Diagnose a psychiatric condition
- Guarantee that a medication will work
- Guarantee that a medication will not cause side effects
- Replace a psychiatric evaluation
- Replace clinical judgment
- Tell you whether you need medication
- Provide a complete treatment plan by itself
A genetic test result should not be used on its own to start, stop, or change a psychiatric medication. Medication decisions should be made with a licensed clinician who understands the full clinical picture.
How Genetic Testing Fits Into Medication Management
At Dignity Brain Health, pharmacogenomic testing may be considered during psychiatric medication management when it could add useful information.
Medication management begins with a clinical evaluation. Your clinician reviews your symptoms, diagnosis, psychiatric history, medical history, prior medications, side effects, treatment goals, safety considerations, and current functioning.
Genetic testing may be considered if you have:
- Tried multiple psychiatric medications without enough benefit
- Had unexpected or difficult side effects
- Needed unusually low or high doses in the past
- Had confusing medication responses
- A complex medication history
- Questions about how your body may process certain medications
Testing is not required for every patient. For some patients, the clinical history is more important than genetic testing. For others, pharmacogenomic information may help guide a more informed medication discussion.
Genetic Testing for Depression, Anxiety, ADHD, PTSD, and OCD
Pharmacogenomic testing may be relevant for patients receiving medication management for conditions such as depression, anxiety, ADHD, PTSD, OCD, PMDD, insomnia, and related mental health concerns.
The value of testing depends on the medication questions being considered. For example, testing may be more useful when a patient has already had multiple medication trials, unclear side effects, or difficulty tolerating standard doses.
It is less useful when the main question is diagnostic, psychological, behavioral, or related to life stressors. Genetic testing does not replace psychiatric evaluation or therapy.
Genetic Testing Near Boston at Dignity Brain Health
Dignity Brain Health is located at:
1101 Beacon Street, Suite 8W
Brookline, MA 02446
Sample collection for pharmacogenomic testing is available in person at our Brookline office near Boston. Collection is typically done with a cheek swab or similar sample method, depending on the test being used.
Follow-up discussion of results may occur as part of your medication management care, when clinically appropriate and available.
Is Genetic Testing Available by Telehealth?
Sample collection for pharmacogenomic testing generally requires an in-person step or a specific collection process. At Dignity Brain Health, sample collection is available at the Brookline office near Boston.
Medication management and follow-up care may be available by telehealth for patients physically located in states where Dignity Brain Health is able to provide care.
If you are interested in pharmacogenomic testing, the first step is to complete the intake process so the team can determine whether the service may be appropriate and how the sample collection process would work.
How the Process Works
1. Medication Management Intake
The first step is to complete the secure online intake. Our team reviews your requested service, location, insurance, clinical needs, and whether pharmacogenomic testing may be relevant.
2. Clinical Evaluation
Your clinician reviews your symptoms, diagnosis, medication history, side effects, prior treatment response, medical history, current medications, and goals.
3. Discussion of Testing
If testing may be useful, your clinician can discuss what the test may show, what it cannot show, cost considerations, insurance questions, and how results would be used.
4. Sample Collection
If you proceed, sample collection is completed according to the test process. At Dignity Brain Health, sample collection is available in person at the Brookline office near Boston.
5. Results Review
When results are available, your clinician reviews them with you in the context of your broader treatment history. The results may inform medication selection, dosing considerations, side-effect monitoring, or future medication discussions.
Insurance and Cost Considerations
Coverage for pharmacogenomic testing varies by insurer and by individual plan. The laboratory test may be billed separately from the clinical visit, depending on the testing process and insurance rules.
Dignity Brain Health accepts many major commercial insurance plans for psychiatric medication management. Coverage varies by clinician, service, state, and individual plan.
Medicare, Medicaid, and MassHealth are not accepted for psychiatric medication management or therapy.
Before proceeding with testing, patients should clarify lab-test costs, insurance coverage, and any out-of-pocket responsibility.
[View Insurance Information]
Why Patients Ask About Genetic Testing
Patients often ask about pharmacogenomic testing after difficult medication experiences.
Common reasons include:
- “I have tried several medications and none helped.”
- “I had side effects at very low doses.”
- “Medication seems to affect me differently than other people.”
- “I want to avoid unnecessary trial and error.”
- “I am worried about starting another psychiatric medication.”
- “I want more information before changing medications.”
These are reasonable questions. Genetic testing may help answer some of them, but not all. The best use of testing is within a careful medication-management relationship.
Frequently Asked Questions
What is genetic testing for psychiatric medications?
Genetic testing for psychiatric medications, also called pharmacogenomic testing, analyzes selected genes that may affect how the body metabolizes or responds to certain medications.
Is pharmacogenomic testing the same as full DNA sequencing?
No. Pharmacogenomic testing is targeted. It looks at selected genes relevant to medication metabolism or response. It is not the same as whole-genome sequencing, ancestry testing, or broad genetic screening.
Can genetic testing tell me which psychiatric medication will work?
No. Genetic testing cannot guarantee that a specific psychiatric medication will work. It may provide information about medication metabolism or tolerability that can help inform clinical decisions.
Can genetic testing diagnose depression, anxiety, ADHD, PTSD, or OCD?
No. Pharmacogenomic testing does not diagnose psychiatric conditions. Diagnosis requires a clinical evaluation.
Can I use genetic testing results to change my medication on my own?
No. You should not start, stop, or change medication based on genetic testing results without guidance from a licensed clinician.
Who might benefit from pharmacogenomic testing?
Testing may be useful for some patients with multiple prior medication trials, unexpected side effects, unusual responses to medication, or complex medication histories. It is not necessary for every patient.
Is genetic testing available near Boston?
Yes. Dignity Brain Health offers pharmacogenomic testing as part of medication management, with sample collection available in person at the Brookline office near Boston.
Is genetic testing available by telehealth?
Sample collection is available in person at the Brookline office. Follow-up medication management care may be available by telehealth when clinically appropriate and when the patient is located in a state where Dignity Brain Health can provide care.
Will insurance cover genetic testing?
Coverage varies by insurer and individual plan. The laboratory test may be billed separately from the clinical visit. Patients should confirm coverage and possible out-of-pocket costs before proceeding.
Is genetic testing required for medication management?
No. Genetic testing is not required for medication management. It is one possible tool that may be considered when clinically useful.
How do I start medication management or ask about genetic testing?
The first step is to complete the secure online intake. Our team will review your requested service, location, insurance, and clinical needs before guiding you toward the appropriate next step.
Key Takeaways
- Pharmacogenomic testing looks at selected genes that may affect psychiatric medication metabolism or response.
- Genetic testing does not diagnose psychiatric conditions and does not guarantee which medication will work.
- Results should be interpreted by a clinician in the context of symptoms, diagnosis, medication history, side effects, and treatment goals.
- Testing may be useful for some patients with multiple prior medication trials, unusual side effects, or complex medication histories.
- At Dignity Brain Health, pharmacogenomic testing may be considered as part of psychiatric medication management, with sample collection available near Boston.
Start Medication Management at Dignity Brain Health
If you have struggled with psychiatric medication side effects, limited benefit, or repeated medication changes, pharmacogenomic testing may be worth discussing as part of a medication-management evaluation.
The first step is to complete Dignity Brain Health’s secure online intake. Our team will review your information and help guide you toward the appropriate next step.
References
Clinical Pharmacogenetics Implementation Consortium. Antidepressant pharmacogenetics guidelines.
U.S. Food and Drug Administration. Pharmacogenetic testing and medication-response claims.
National Institutes of Health. Pharmacogenomic testing for neuropsychiatric medications.
Medical Disclaimer
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Pharmacogenomic testing and psychiatric medication management should be pursued only under the supervision of a licensed clinician who has reviewed the patient’s full medical and psychiatric history. Genetic testing results should be interpreted in the context of the complete clinical picture. If you are in immediate danger or may harm yourself, call 911, call or text 988, or go to the nearest emergency department.